Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis and an Inadequate Response to Tumour Necrosis Factor Inhibitors in the Phase III, Randomised Controlled Trial: OPAL Beyond

RMD Open - United Kingdom
doi 10.1136/rmdopen-2018-000808
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

AB0794 Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis: Results From Two Phase 3 Studies

2017English

Improved Patient-Reported Outcomes in Patients With Psoriatic Arthritis Treated With Abatacept: Results From a Phase 3 Trial

Arthritis Research & Therapy
2018English

Ixekizumab Is Efficacious When Used Alone or When Added to Conventional Synthetic Disease-Modifying Antirheumatic Drugs (cDMARDs) in Patients With Active Psoriatic Arthritis and Previous Inadequate Response or Intolerance to Tumour Necrosis Factor Inhibitors

RMD Open
RheumatologyAllergyImmunology
2018English

Adalimumab Improves Joint-Related and Skin-Related Functional Impairment in Patients With Psoriatic Arthritis: Patient-Reported Outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
2006English

Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials

RMD Open
RheumatologyAllergyImmunology
2017English

Randomized Trial of Tofacitinib in Active Ulcerative Colitis: Analysis of Efficacy Based on Patient-Reported Outcomes

BMC Gastroenterology
MedicineGastroenterology
2015English

Patient-Reported Outcomes for Tofacitinib With and Without Methotrexate, or Adalimumab With Methotrexate, in Rheumatoid Arthritis: A Phase IIIB/IV Trial

RMD Open
RheumatologyAllergyImmunology
2019English

Longterm (52-Week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients With Psoriatic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2015English

Cost-Effectiveness of Combination Disease-Modifying Antirheumatics vs. Tumour Necrosis Factor Inhibitors in Active Rheumatoid Arthritis: TACIT Trial

Arthritis Care and Research
Rheumatology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy